Element Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Element Capital Management LLC

  • $1.29 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$76.01 - $99.03 $6.4 Million - $8.34 Million
-84,170 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $5.45 Million - $6.5 Million
-70,221 Reduced 45.48%
84,170 $6.82 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $12.5 Million - $14.7 Million
154,391
154,391 $13.8 Million

Others Institutions Holding BMRN

# of Institutions
631
Shares Held
184M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email